Animal Pharmaceuticals Market Research Report by Type (Vaccine and Veterinary Drugs), by Product (Anti-Inflammatories, Bronchodilators, and Ectoparasiticides), by Application, by End User, by Region (Americas, Asia-Pacific, and Europe, Middle East & Afric

Animal Pharmaceuticals Market Research Report by Type (Vaccine and Veterinary Drugs), by Product (Anti-Inflammatories, Bronchodilators, and Ectoparasiticides), by Application, by End User, by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

The Global Animal Pharmaceuticals Market size was estimated at USD 16.45 billion in 2020 and expected to reach USD 17.68 billion in 2021, at a CAGR 7.82% to reach USD 25.84 billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.


Market Segmentation & Coverage:

This research report categorizes the Animal Pharmaceuticals to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market was studied across Vaccine and Veterinary Drugs.

Based on Product, the market was studied across Anti-Inflammatories, Bronchodilators, Ectoparasiticides, and Endoparasiticides.

Based on Application, the market was studied across Companion Animal and Poultry.

Based on End User, the market was studied across Hospitals, Laboratories, and Veternary Clinics.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Animal Pharmaceuticals Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Animal Pharmaceuticals Market, including Aratana Therapeutics, Inc., Bayer AG, BioPredic International, Boehringer Ingelheim International GmbH, Ceva Animal Health LLC – Biomune, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Dechra Veterinary Products USA, Elanco Animal Health Inc., Eli Lilly & Company, Huvepharma, Inc., Liberty Pharma INC, Merck & Co., Inc., Perrigo Company plc, Sanofi, Sparhawk Laboratories, Vetoquinol S.A., Virbac SA, Zoetis Inc., and Zoetis, Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Animal Pharmaceuticals Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Animal Pharmaceuticals Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Animal Pharmaceuticals Market?
4. What is the competitive strategic window for opportunities in the Global Animal Pharmaceuticals Market?
5. What are the technology trends and regulatory frameworks in the Global Animal Pharmaceuticals Market?
6. What is the market share of the leading vendors in the Global Animal Pharmaceuticals Market?
7. What modes and strategic moves are considered suitable for entering the Global Animal Pharmaceuticals Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Introduction
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Rising adoption of pets across the globe
5.2.2. Increasing cases of zoonotic and chronic diseases
5.2.3. Livestock population experiencing rapid growth
5.2.4. Government mandatory medication and vaccination
5.3. Restraints
5.3.1. Several risk factors associated with animal health APIs
5.4. Opportunities
5.4.1. Increasing awareness and expenditure among people regarding animal healthcare
5.4.2. Development of new products
5.4.3. Unmet animal needs in many countries
5.5. Challenges
5.5.1. Limited awareness and availability in low-income areas
6. Animal Pharmaceuticals Market, by Type
6.1. Introduction
6.2. Vaccine
6.3. Veterinary Drugs
7. Animal Pharmaceuticals Market, by Product
7.1. Introduction
7.2. Anti-Inflammatories
7.3. Bronchodilators
7.4. Ectoparasiticides
7.5. Endoparasiticides
8. Animal Pharmaceuticals Market, by Application
8.1. Introduction
8.2. Companion Animal
8.3. Poultry
9. Animal Pharmaceuticals Market, by End User
9.1. Introduction
9.2. Hospitals
9.3. Laboratories
9.4. Veternary Clinics
10. Americas Animal Pharmaceuticals Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Animal Pharmaceuticals Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Animal Pharmaceuticals Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Aratana Therapeutics, Inc.
14.2. Bayer AG
14.3. BioPredic International
14.4. Boehringer Ingelheim International GmbH
14.5. Ceva Animal Health LLC – Biomune
14.6. Ceva Sante Animale
14.7. Dechra Pharmaceuticals PLC
14.8. Dechra Veterinary Products USA
14.9. Elanco Animal Health Inc.
14.10. Eli Lilly & Company
14.11. Huvepharma, Inc.
14.12. Liberty Pharma INC
14.13. Merck & Co., Inc.
14.14. Perrigo Company plc
14.15. Sanofi
14.16. Sparhawk Laboratories
14.17. Vetoquinol S.A.
14.18. Virbac SA
14.19. Zoetis Inc.
14.20. Zoetis, Inc.
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 3. GLOBAL ANIMAL PHARMACEUTICALS MARKET: MARKET DYNAMICS
FIGURE 4. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 5. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2020 VS 2026 (USD BILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2026
FIGURE 7. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2026 (USD BILLION)
FIGURE 8. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 9. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2026 (USD BILLION)
FIGURE 10. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 11. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 12. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD BILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2026
FIGURE 14. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2026 (USD BILLION)
FIGURE 15. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 16. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY BRONCHODILATORS, 2018-2026 (USD BILLION)
FIGURE 17. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 18. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ECTOPARASITICIDES, 2018-2026 (USD BILLION)
FIGURE 19. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 20. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ENDOPARASITICIDES, 2018-2026 (USD BILLION)
FIGURE 21. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 22. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 23. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2026
FIGURE 25. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMAL, 2018-2026 (USD BILLION)
FIGURE 26. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 27. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY POULTRY, 2018-2026 (USD BILLION)
FIGURE 28. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY POULTRY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 29. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 30. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2020 VS 2026 (USD BILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2026
FIGURE 32. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2026 (USD BILLION)
FIGURE 33. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 34. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY LABORATORIES, 2018-2026 (USD BILLION)
FIGURE 35. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY LABORATORIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 36. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERNARY CLINICS, 2018-2026 (USD BILLION)
FIGURE 37. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERNARY CLINICS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 38. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 39. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 40. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 41. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 42. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 43. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 44. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 45. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 46. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 47. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 48. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 49. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 50. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 51. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 52. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 53. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 54. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 55. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 57. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 58. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 59. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 60. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 61. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 62. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 63. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 64. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 65. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 66. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 67. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 68. GLOBAL ANIMAL PHARMACEUTICALS MARKET: FPNV POSITIONING MATRIX
FIGURE 69. GLOBAL ANIMAL PHARMACEUTICALS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 70. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANIMAL PHARMACEUTICALS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL ANIMAL PHARMACEUTICALS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY POULTRY, BY REGION, 2018-2026 (USD BILLION)
TABLE 15. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 16. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD BILLION)
TABLE 17. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 18. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERNARY CLINICS, BY REGION, 2018-2026 (USD BILLION)
TABLE 19. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 20. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 21. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 22. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 23. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 24. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 25. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 26. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 27. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 28. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 29. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 30. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 31. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 32. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 33. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 43. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 45. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 46. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 47. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 48. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 49. GLOBAL ANIMAL PHARMACEUTICALS MARKET: SCORES
TABLE 50. GLOBAL ANIMAL PHARMACEUTICALS MARKET: BUSINESS STRATEGY
TABLE 51. GLOBAL ANIMAL PHARMACEUTICALS MARKET: PRODUCT SATISFACTION
TABLE 52. GLOBAL ANIMAL PHARMACEUTICALS MARKET: RANKING
TABLE 53. GLOBAL ANIMAL PHARMACEUTICALS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 54. GLOBAL ANIMAL PHARMACEUTICALS MARKET: MERGER & ACQUISITION
TABLE 55. GLOBAL ANIMAL PHARMACEUTICALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 56. GLOBAL ANIMAL PHARMACEUTICALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 57. GLOBAL ANIMAL PHARMACEUTICALS MARKET: INVESTMENT & FUNDING
TABLE 58. GLOBAL ANIMAL PHARMACEUTICALS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 59. GLOBAL ANIMAL PHARMACEUTICALS MARKET: LICENSE & PRICING

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook